Programmed Death 1 (PD-1) Expression in Relapsing and Remitting Hodgkin Lymphoma as Prognostic Factor.

Bouzari, Behnaz; Basi, Ali; Dadkhah, Shadi; Panahi, Mahshid; Mohammadi, Soha

Bouzari, Behnaz; Basi, Ali; Dadkhah, Shadi; Panahi, Mahshid; Mohammadi, Soha.

Afiliación

Bouzari B; Department of Pathology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Basi A; Department of Hematology Oncology, School of Medicine, Firouzgar Hospital, Iran University of Medical Sciences, Tehran, Iran.
Dadkhah S; Department of Pathology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Panahi M; Department of Pathology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Mohammadi S; School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Asian Pac J Cancer Prev ; 24(8): 2829-2835, 2023 Aug 01.

Article en En | MEDLINE | ID: mdl-37642071

Asunto(s)

Enfermedad de Hodgkin; Humanos; Masculino; Femenino; Adulto; Antígeno B7-H1; Pronóstico; Receptor de Muerte Celular Programada 1; Estudios Transversales; Estudios Retrospectivos; Recurrencia Local de Neoplasia

Palabras clave

Hodgkin' s Lymphoma; PD-L1; expression levels; immunohistochemistry

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin Tipo de estudio: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Asian Pac J Cancer Prev Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Irán

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google